Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Sustained release ranolazine formulations

US Patent 6525057 · Granted Feb 25, 2003

Estimated economic value: $6,625,000

Assignee

Inventors

View full patent text on Google Patents →